DCM
GILD icon

Delpha Capital Management’s Gilead Sciences GILD Stock Holding History

Delpha Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-157
Closed -$11K – 550
2017
Q4 		$11K Buy
+157
New +$11.9K 0.01% 1029

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Delpha Capital Management's GILD Position: Q1 2018 in Review

Delpha Capital Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 157 shares — an estimated $11K sold.

Delpha Capital Management first reported a position in GILD in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Delpha Capital Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 157 Gilead Sciences shares in Q1 2018, an estimated $11K.
  • Delpha Capital Management first reported a position in Gilead Sciences in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Gilead Sciences position peaked at $11K in Q4 2017.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.